4-(3-hydroxy-3H-naphtho[1,2-e][1,2]oxaborinin-2-yl)benzene-1,2-diol

Names and Identifiers

Canonical SMILES: OB1Oc2ccc3ccccc3c2C=C1c1ccc(O)c(O)c1

Standard InChI: InChI=1S/C18H13BO4/c20-16-7-5-12(9-17(16)21)15-10-14-13-4-2-1-3-11(13)6-8-18(14)23-19(15)22/h1-10,20-22H

Standard InChI Key: RFQVGAZBZAZFKR-UHFFFAOYSA-N

Molfile:

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   35.8188   -3.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8177   -4.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5257   -4.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2354   -4.1497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2325   -3.3270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5239   -2.9218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9387   -2.9158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6453   -3.3240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6414   -1.6905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.9311   -2.1000    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
   37.2217   -1.6944    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.3505   -2.0986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3464   -2.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7607   -2.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0553   -1.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7606   -2.9207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0513   -3.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0460   -4.1364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7492   -4.5487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4593   -4.1415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4611   -3.3293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1110   -2.9222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.1096   -4.5582    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  7 10  1  0
  8 13  1  0
 12  9  1  0
  9 10  1  0
 10 11  1  0
 12 13  2  0
 13 17  1  0
 16 14  1  0
 14 15  2  0
 15 12  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  2  0
  1 22  1  0
  2 23  1  0
M  END

Alternative Forms

Parent:

ALA4534352
---

Associated Targets(Human)

APP Tclin Amyloid-beta A4 protein (8510 Activities)

Discover Target: APP

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Unknown	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 304.11	Molecular Weight (Monoisotopic): 304.0907	AlogP: ┄	#Rotatable Bonds: ┄
Polar Surface Area: ┄	Molecular Species: ┄	HBA: ┄	HBD: ┄
#RO5 Violations: ┄	HBA (Lipinski): ┄	HBD (Lipinski): ┄	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: ┄	CX Basic pKa: ┄	CX LogP: ┄	CX LogD: ┄
Aromatic Rings: ┄	Heavy Atoms: ┄	QED Weighted: ┄	Np Likeness Score: ┄

References

1. Lu CJ, Hu J, Wang Z, Xie S, Pan T, Huang L, Li X.. (2018) Discovery of boron-containing compounds as Aβ aggregation inhibitors and antioxidants for the treatment of Alzheimer's disease., 9 (11): [PMID:30568754] [10.1039/C8MD00315G]

Source

Source(1):

Scientific Literature